Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.58 |
| ▸ | FBP1 | P09467 | 1/20 | 0.52 |
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27597826 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL598776 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL23458002 | 0.82 | AKR1C3 (0.73) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL60657 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL6433811 | 0.82 | AKR1C3 (0.73) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL27855636 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| Ammonia Solution, Strong SCHEMBL28447731 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL11801120 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL1123464 | 0.78 | ALDH1A1 (0.54) | ALDH1A1TSHRAKR1C3FBP1KDM1A | |
| SCHEMBL585075 | 0.78 | ALDH1A1 (0.54) | ALDH1A1TSHRAKR1C3FBP1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| CN-119191982-A | Apricot kernel fruit-flavored compound, preparation method thereof and Huang Xingguo-flavored essence | 波顿香料股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-20220064191-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2022-03-03 | — | — | US | claimed |
| EP-3218425-B1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2017196762-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-16 | — | — | WO | claimed |
| US-20170327647-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2017-11-16 | — | — | US | claimed |
| EP-3218425-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2017-09-20 | — | — | EP | claimed |
| WO-2016077513-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2016-05-19 | — | — | WO | claimed |
| US-20160137674-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2016-05-19 | — | — | US | claimed |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | disclosed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | disclosed |
| CN-119191982-A | Apricot kernel fruit-flavored compound, preparation method thereof and Huang Xingguo-flavored essence | 波顿香料股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20220177813-A1 | TREATMENT COMPOSITIONS WITH PRO-FRAGRANCE SILICONE POLYMERS THAT COMPRISE HETEROCYCLIC MOIETIES | THE PROCTER & GAMBLE COMPANY | 2022-06-09 | — | — | US | disclosed |
| US-20220064191-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2022-03-03 | — | — | US | disclosed |
| US-20170327647-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2017-11-16 | — | — | US | disclosed |
| EP-3218425-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2017-09-20 | — | — | EP | disclosed |
| WO-2016077513-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2016-05-19 | — | — | WO | disclosed |
| US-20160137674-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2016-05-19 | — | — | US | disclosed |
| EP-0848015-A1 | Catalyst for the production of functionalized polymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137674-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | ALDH1A1 3917/4885TSHR 3842/4885AKR1C3 3548/4885 |
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | ALDH1A1 3917/4885TSHR 3842/4885AKR1C3 3548/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | ALDH1A1 3361/4885TSHR 3016/4885AKR1C3 3449/4885 |
| US-20220064191-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | ALDH1A1 3917/4885TSHR 3842/4885AKR1C3 3548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.